Preparation of Gβ 1 γ 2 from Sf9 cells. All experiments utilized either wt geranylgeranylated Gβ 1 γ 2 or biotin tagged geranylgeranylated Gβ 1 γ 2 (bGβ 1 γ 2 ) purified from sf9 cells essentially as has been described (2) (3) (4) . For biotinylation, a biotin acceptor sequence was fused at the N terminus of Gβ 1 and used to create a baculovirus that coexpresses bGβ 1 and biotin holoenzyme synthetase (BirA). This virus was used to coinfect Sf9 cells with wt Gγ 2 and 6His-Gα i1 viruses. bGβ 1 γ 2 was purified by NiAgarose via the bound 6His-Gα i1 . Biotinylation was confirmed by blotting with streptavidin linked horse radish peroxidase or with pulldown with streptavidin agarose.
Competition Phage ELISA: Small molecule inhibition of SIGK peptide binding was assessed in a phage ELISA essentially as described (5) . Briefly, 25 nM biotinylated Gβ 1 γ 2 was immobilized in a streptavidin coated 96 well plate. Compounds and 1x10 10 phage displaying the SIGK peptide, were simultaneously added and incubated for 1hr. The binding of phage was assessed via addition of a horse radish peroxidase conjugated anti-M13 antibody and monitoring A 405 upon addition of ABTS.
Measurement of Gα−βγ interactions:
Blocking of binding of 200 pM Fluorescein isothiocyanate-labeled α i1 (F-αi1) to 50 pM bβγ by compounds was measured via flow cytometry as described (4, 6) .
Measurement of PLCβ activation:
Measurement of Gβγ dependent activation of PLCβ2 and PLCβ3 was preformed as described (7) . Protein amounts were as follows: 0.25 ng PLCβ2, 0.5 ng PLCβ3 and 100 nM Gβ 1 γ 2 . Data shown is representative of at least three independent experiments.
Measurement of PI3Kγ activation:
Activation of PI3Kγ was performed as described (8) . Reactions were performed in lipid micelles comprised of 600 μM PE and 300 μM PI with 10 ng of purified PI3Kγ. PI3Kγ activity was assayed with or without 100 nM Gβ 1 γ 2 in the presence or absence of compounds. The experiment was performed 3 times with similar results.
Pull down of GRK2 with biotinylated Gβ 1 γ 2 : 250 nM bGβγ was incubated with 25 μL streptavidin agarose beads in a final volume of 100 μL of buffer A (50 mM HEPES (pH 8), 3 mM MgCl 2 , 0.1mM EDTA, 100 mM NaCl and 0.5% C 12 E 10 ) at 4°C for 1.5 hours. The agarose beads were centrifuged and resuspended in 100 μL buffer A with 25 nM purified GRK2 and compounds and incubated for 1 hour at room temperature with mixing. The beads were washed three times with 500 μL buffer A, 50 μl of 2x SDS sample buffer was added and followed by boiling for 5 min, separation by SDS-PAGE and transferred to nitrocellulose. Membranes were probed with a 1:1000 dilution of anti-GRK2 antibody followed by 1:10,000 dilution of anti-rabbit HRP. Blots were developed with Enhanced Chemiluminescence reagents (ECL) and exposed to film.
Measuring cytosolic Ca
2+ release in differentiated HL-60 cells or M3-HEK-293 cells: HL-60 cells were seeded in a 75 mm 2 flasks at a density of 0.1x10 6 cells/mL in 35 mL of RPMI 1640 containing 10% FBS, penicillin and streptomycin. DMSO was added to 1.2% and cells were allowed to differentiate at 37°C (5% CO 2 ) for 72 hours. After differentiation, cells were washed with Hepes Buffered Saline Solution (HBSS) and resuspended in 1 mL HBSS. Fura-2 was added to 1 μM and cells were incubated at 37°C for 45 min. Cells were centrifuged at 1000xg and washed once with HBSS. Cells were resuspended in 1 mL HBSS and placed on ice. 140 μL of cells were diluted into 1860 μL of HBSS at 23 o C in a quartz cuvette and placed into a Photon Technology International (PTI) fluorimeter for analysis. For M3-expressing HEK-293 cells, cells were labeled with 1 μM Fura-2 while adherent. After loading cells were suspended in 1 mL HBSS an 100 μl of cells were diluted into 1900 μL of HBSS as above. Excitation wavelengths were 340 and 380 nm emission was monitored at 510 nm. After a 3 minute incubation to obtain a stable baseline, DMSO or compounds were added followed after 5 minutes by the addition of agonist. Data was analyzed in Felix ver.1.1 and graphs were generated using Graph Pad Prism 4 software.
Translocation of GFP-PHAKT in HL-60 cells:
HL-60 cells stably over-expressing a GFP-tagged PH domain from AKT(9) were seeded at 0.25x10 6 cells/ml as described above. Cells were differentiated with 1.2% DMSO for 72 hours. For the experiments cells were washed and resuspended in 8 mL of serum free RPMI 1640. One mL aliquots of cells were pretreated with compounds for 5 min. at room temperature. fMLP was added and cells were transferred to a 37°C water bath for 2 min. Cells were then placed on ice, pelleted at 4°C and the pellets resuspended in 100 μL lysis buffer (50 mM HEPES (pH 8), 3mM MgCl 2 , 0.1 mM EDTA, 100 mM NaCl, 50 μM Na 3 VO 4 , and protease inhibitors). Cells were subjected to 4 freeze-thaw cycles in liquid N 2 , and membranes were obtained by centrifugation at 100,000xg for 20 min. Pellets were washed with 100 μL lysis buffer and resuspended in 60 μL 2x sample buffer. Samples were resolved by 12% SDS-PAGE, and transferred to nitrocellulose. Membranes were probed with a 1:2000 dilution of anti-GFP antibody followed by a 1:10,000 dilution of HRP conjugated anti-mouse antibody. Blots were developed with ECL and chemiluminescence quantitatively analyzed with a CCD camera in a UVP Epi-Chem II Darkroom imaging system.
ERK1 and ERK2 activation in HL-60 cells:
HL-60 cells were seeded at 0.25x10 6 cells/mL as described previously. 1.2% DMSO was added and cells were incubated for 56 hours. Cells were then washed and resuspended in 35 mL serum-free RPMI with 1.2% DMSO and incubated for an additional 16 hours. For the experiment cells were pelleted, washed in serum-free RPMI and resuspended in 8 mL serum-free RPMI. 1 mL aliquots of cells were treated with compounds for 5 minutes. fMLP or mSIRK was added and cells were transferred to a 37°C water bath for 5 min. Cells were transferred to ice, pelleted at 4°C and were resuspsended in 60 μL 2x SDS sample buffer. Samples were resolved by 12% SDS-PAGE, and transferred to nitrocellulose. Membranes were probed with a 1:1000 dilution of antibody to total ERK or phospho-ERK followed by a 1:10000 dilution of HRP conjugated anti-rabbit antibody. Membranes were developed with ECL reagents and exposed to film.
Mouse tail-flick assay: Male, ICR mice (20-30 g) or PLCβ3 -/-(C57/Bl6) received either morphine alone or morphine and M119 concomitantly. All injections were administered intracerebroventricularly (i.c.v.). Antinociception was assessed 20 min after injections using the 55°C warm-water tail flick test as previously described (10) . A maximum score was assigned (100%) to animals not responding within 15 sec to avoid tissue damage. Antinociception was calculated by the following formula: % antinociception = 100 x (test latency -control latency)/(15 -control latency).
Animals: Mice were housed in groups of five with food and water available ad libitum until the time of the experiment. Animals were maintained on a 12-hr light/dark cycle in a temperature-controlled animal colony. Studies were carried out in accordance with the Guide for the Care and Use of Laboratory Animals as adopted by the NIH. GRK2 translocation: 3 day differentiated HL-60 cells in 1mL serum free RPMI medium were treated with 250 nM fMLP for 1 min prior to incubation on ice. Cells were centrifuged and resuspended in 100 μL of lysis buffer (50 mM Hepes, pH 8.0, 100 mM NaCl, 3 mM MgCl 2 , 0.1 mM EDTA, 50 μM Na 3 VO 4 , and protease inhibitors) followed by 4x freeze-thaw and centrifugation at 100,000 x g for 20 min. Pellets were washed once with lysis buffer followed by resuspension in SDS sample buffer, gel electrophoresis and western blotting with GRK2 antibody followed by quantitative chemiluminescence imaging. Table 3 . M119 has no analgesic effects independent of morphine coadministration. Mice were injected intracerebrovetricularly with 100 nmol M119 and mice were analyzed in the 55 tail flick test as described in Fig 4. Measurements were taken prior to injection (baseline) and at the indicated times after injection. 
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